Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longshan Ji

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Immunology Research|May 15, 2024
Hepatitis B: Model Systems and Therapeutic ApproachesXiaoxiao Yu, Yating Gao, Xin Zhang, et al.
Journal of Hepatocellular Carcinoma|February 18, 2022
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular CarcinomaYuyao Li, Yue Li, Jinghao Zhang, et al.
Clinical and Experimental Medicine|June 18, 2025
The application performance of MRI-PDFF detection values of different hepatic lobes in diagnosing liver steatosisFengjie Qiao, Yan Xue, Chen Zou, et al.
Journal of Ethnopharmacology|March 20, 2024
Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsetsLongshan Ji, Jinghan Wei, Rongjie Zhang, et al.
Acta Pharmaceutica Sinica. B|September 30, 2022
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug <i>Potentilla discolor</i> BungeLongshan Ji, Qian Li, Yong He, et al.
Journal of Virus Eradication|October 27, 2025
Serum osteopontin levels predict short-term outcomes in patients with hepatitis B-related acute-on-chronic liver failureYu Liu, Miao Fang, Hongying Guo, et al.
Frontiers in Pharmacology|January 30, 2023
Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implicationsYu Liu, Wei Yuan, Miao Fang, et al.
Heliyon|November 30, 2023
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinomaRongjie Zhang, Qian Li, Xiaoxiao Yu, et al.
Journal for Immunotherapy of Cancer|May 26, 2022
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinomaZhuo Yu, Yuyao Li, Yue Li, et al.
Hepatology Communications|March 25, 2025
Multiple cell-type interactions drive invariant NKT cell hepatitisJiaxin Tan, Longshan Ji, Qian Li, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Immunology Research|May 15, 2024
Hepatitis B: Model Systems and Therapeutic ApproachesXiaoxiao Yu, Yating Gao, Xin Zhang, et al.
Journal of Hepatocellular Carcinoma|February 18, 2022
Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular CarcinomaYuyao Li, Yue Li, Jinghao Zhang, et al.
Clinical and Experimental Medicine|June 18, 2025
The application performance of MRI-PDFF detection values of different hepatic lobes in diagnosing liver steatosisFengjie Qiao, Yan Xue, Chen Zou, et al.
Journal of Ethnopharmacology|March 20, 2024
Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsetsLongshan Ji, Jinghan Wei, Rongjie Zhang, et al.
Acta Pharmaceutica Sinica. B|September 30, 2022
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug <i>Potentilla discolor</i> BungeLongshan Ji, Qian Li, Yong He, et al.
Journal of Virus Eradication|October 27, 2025
Serum osteopontin levels predict short-term outcomes in patients with hepatitis B-related acute-on-chronic liver failureYu Liu, Miao Fang, Hongying Guo, et al.
Frontiers in Pharmacology|January 30, 2023
Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implicationsYu Liu, Wei Yuan, Miao Fang, et al.
Heliyon|November 30, 2023
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinomaRongjie Zhang, Qian Li, Xiaoxiao Yu, et al.
Journal for Immunotherapy of Cancer|May 26, 2022
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinomaZhuo Yu, Yuyao Li, Yue Li, et al.
Hepatology Communications|March 25, 2025
Multiple cell-type interactions drive invariant NKT cell hepatitisJiaxin Tan, Longshan Ji, Qian Li, et al.
Pageof 2